Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A loss-of-function polymorphism in the propeptide of lysyl oxidase exacerbates atherosclerosis.
Journal: JCI insight
Published: October 29, 2025
Decoding the Therapeutic Target SVEP1: Harnessing Molecular Trait GWASs to Unravel Mechanisms of Human Disease.
Journal: Annual review of pharmacology and toxicology
Published: January 23, 2025
Single cell variant to enhancer to gene map for coronary artery disease.
Journal: medRxiv : the preprint server for health sciences
Published: November 28, 2024
The Uses and Misuses of Mendelian Randomization in Clinical and Translational Science.
Journal: JACC. Basic to translational science
Published: August 22, 2024
Instrumental variable and colocalization analyses identify endotrophin and HTRA1 as potential therapeutic targets for coronary artery disease.
Journal: iScience
Published: October 10, 2023
The emerging Janus face of SVEP1 in development and disease.
Journal: Trends in molecular medicine
Published: June 06, 2023
ANGPTL3 deficiency impairs lipoprotein production and produces adaptive changes in hepatic lipid metabolism.
Journal: Journal of lipid research
Published: May 22, 2023
Author Correction: SVEP1 is an endogenous ligand for the orphan receptor PEAR1.
Journal: Nature communications
Published: March 18, 2023
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis.
Journal: Research square
Published: February 07, 2023
Targeting immune-fibroblast cell communication in heart failure.
Journal: Nature
Published: December 21, 2022
A mutational hotspot in AMOTL1 defines a new syndrome of orofacial clefting, cardiac anomalies, and tall stature.
Journal: American journal of medical genetics. Part A
Published: November 18, 2022
SVEP1 is an endogenous ligand for the orphan receptor PEAR1.
Journal: Nature communications
Published: July 28, 2022
Last Updated: 09/26/2026